These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32570728)

  • 1. Prospects of and Barriers to the Development of Epitope-Based Vaccines against Human Metapneumovirus.
    Stepanova E; Matyushenko V; Rudenko L; Isakova-Sivak I
    Pathogens; 2020 Jun; 9(6):. PubMed ID: 32570728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
    Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
    J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Evaluation of a Multi-Epitope Peptide of Human Metapneumovirus.
    Li X; Guo L; Kong M; Su X; Yang D; Zou M; Liu Y; Lu L
    Intervirology; 2015; 58(6):403-12. PubMed ID: 27096202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization of M8C10, a neutralizing antibody targeting a highly conserved prefusion-specific epitope on the metapneumovirus fusion trimerization interface.
    Xiao X; Wen Z; Chen Q; Shipman JM; Kostas J; Reid JC; Warren C; Tang A; Luo B; O'Donnell G; Fridman A; Chen Z; Vora KA; Zhang L; Su H-P; Eddins MJ
    J Virol; 2023 Dec; 97(12):e0105223. PubMed ID: 38032197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current developments and prospects on human metapneumovirus vaccines.
    Márquez-Escobar VA
    Expert Rev Vaccines; 2017 May; 16(5):419-431. PubMed ID: 28116910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical human metapneumovirus isolates show distinct pathogenesis and inflammatory profiles but similar CD8
    Sojati J; Zhang Y; Williams JV
    mSphere; 2024 Jan; 9(1):e0057023. PubMed ID: 38197640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice.
    Herd KA; Mahalingam S; Mackay IM; Nissen M; Sloots TP; Tindle RW
    J Virol; 2006 Feb; 80(4):2034-44. PubMed ID: 16439559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel HLA-A2-restricted human metapneumovirus epitopes reduce viral titers in mice and are recognized by human T cells.
    Hastings AK; Gilchuk P; Joyce S; Williams JV
    Vaccine; 2016 May; 34(24):2663-70. PubMed ID: 27105560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility complex class I cytotoxic T lymphocyte immunity to human metapneumovirus (hMPV) in individuals with previous hMPV infection and respiratory disease.
    Herd KA; Nissen MD; Hopkins PM; Sloots TP; Tindle RW
    J Infect Dis; 2008 Feb; 197(4):584-92. PubMed ID: 18240952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Metapneumovirus Reinfection in Aged Mice Recapitulates Increased Disease Severity in Elderly Humans Infected with Human Metapneumovirus.
    Parks OB; Eddens T; Zhang Y; Oury TD; McElroy A; Williams JV
    Immunohorizons; 2023 Jun; 7(6):398-411. PubMed ID: 37261717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus.
    Ma S; Zhu F; Xu Y; Wen H; Rao M; Zhang P; Peng W; Cui Y; Yang H; Tan C; Chen J; Pan P
    Hum Vaccin Immunother; 2023 Dec; 19(3):2293300. PubMed ID: 38172569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.
    Hastings AK; Erickson JJ; Schuster JE; Boyd KL; Tollefson SJ; Johnson M; Gilchuk P; Joyce S; Williams JV
    J Virol; 2015 Apr; 89(8):4405-20. PubMed ID: 25653440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice.
    Lévy C; Aerts L; Hamelin MÈ; Granier C; Szécsi J; Lavillette D; Boivin G; Cosset FL
    Vaccine; 2013 Jun; 31(25):2778-85. PubMed ID: 23583815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats.
    Cseke G; Wright DW; Tollefson SJ; Johnson JE; Crowe JE; Williams JV
    J Virol; 2007 Jan; 81(2):698-707. PubMed ID: 17050599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with a recombinant bacillus Calmette-Guerin strain confers protective Th1 immunity against the human metapneumovirus.
    Palavecino CE; Céspedes PF; Gómez RS; Kalergis AM; Bueno SM
    J Immunol; 2014 Jan; 192(1):214-23. PubMed ID: 24319265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein.
    Rappazzo CG; Hsieh CL; Rush SA; Esterman ES; Delgado T; Geoghegan JC; Wec AZ; Sakharkar M; Más V; McLellan JS; Walker LM
    Immunity; 2022 Sep; 55(9):1710-1724.e8. PubMed ID: 35944529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of temperature-sensitive human metapneumovirus strains that provide protective immunity in hamsters.
    Herfst S; de Graaf M; Schrauwen EJA; Sprong L; Hussain K; van den Hoogen BG; Osterhaus ADME; Fouchier RAM
    J Gen Virol; 2008 Jul; 89(Pt 7):1553-1562. PubMed ID: 18559924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of Live Chimeric Vaccines against Human Metapneumovirus.
    Ogonczyk Makowska D; Hamelin MÈ; Boivin G
    Pathogens; 2020 Feb; 9(2):. PubMed ID: 32093057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination approaches to combat human metapneumovirus lower respiratory tract infections.
    Herfst S; Fouchier RA
    J Clin Virol; 2008 Jan; 41(1):49-52. PubMed ID: 18054841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.
    Russell CJ; Jones BG; Sealy RE; Surman SL; Mason JN; Hayden RT; Tripp RA; Takimoto T; Hurwitz JL
    Virology; 2017 Sep; 509():60-66. PubMed ID: 28605636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.